The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells
Authors
Keywords
histone methyltransferase, EZH2 inhibitors, hedgehog pathway, medulloblastoma stem-like cells, self-renewal
Journal
Oncotarget
Volume 8, Issue 40, Pages -
Publisher
Impact Journals, LLC
Online
2017-08-02
DOI
10.18632/oncotarget.19782

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.